logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
Back
D

Devendra Hiwase

Central Adelaide Local Health Network

31H-index
296Paper Count
3.1KCitation Count
Published Papers 67
Publication Date
logo
Methylation Mesa define functional regulatory elements for targeted gene activation
errNature Communications
IF15.7
err2026-08-26
err0
errOAAI
errY. V. Liu; J. Suryatenggara; H. Wong; M. K. Jayasinghe; J. P. Tang; H. K. Tan; J. Kwon; Q. Zhou; J. Zhang; S. Moein; S. Ummarino; M. T. N. Le; J. G. Doench; T. Benoukraf; L. Chai; D. Hiwase; D. Thomas; A. Di Ruscio; D. G. Tenen; M. A. Bassal
errShare
errSave
Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax—an analysis from the International Consortium for MDS (icMDS) VALIDATE database
errBlood Cancer Journal
IF11.6
err2026-06-29
err0
errOAAI
errJan Philipp Bewersdorf; Tariq Kewan; Luca Lanino; Wei Wei; Tulika Rudra Gupta; Jessica M. Stempel; Najla H. Al Ali; Amy E. DeZern; Mikkael A. Sekeres; Geoffrey L. Uy; Samuel Urrutia; Hetty E. Carraway; Pinkal Desai; Elizabeth A. Griffiths; Eytan M. Stein; Andrew M. Brunner; Christine McMahon; Rory M. Shallis; Joshua F. Zeidner; Michael R. Savona; Hayley Hawkins; Namrata Sonia Chandhok; Constantine N. Logothetis; Aram Bidikian; Ted M. Getz; Gail J. Roboz; Benjamin Rolles; Eunice S. Wang; Amyah C. Harris; Maria L. Amaya; Somedeb Ball; Justin Grenet; Zhuoer Xie; Yazan F. Madanat; Yasmin Abaza; Talha Badar; Jaclynn Campos; Torsten Haferlach; Jaroslaw P. Maciejewski; David Sallman; Anoop Enjeti; Kamal Al-Rabi; Khalid Halahleh; Devendra Hiwase; Maria Diez-Campelo; David Valcarcel; Claudia Haferlach; Lisa Pleyer; Ioannis Kotsianidis; Vassiliki Pappa; Valeria Santini; Angela Consagra; Aref Al-Kali; Seishi Ogawa; Yasuhito Nannya; Maximilian Stahl; Matteo Giovanni Della Porta; Rami S. Komrokji; Amer M. Zeidan
errShare
errSave
Pre-transplant azacitidine does not improve survival in allogeneic HSCT for higher-risk MDS
errBone Marrow Transplantation
IF5.2
err2026-04-23
err0
PREAI
errMiles Horton; Becky Leung; Ricky Nelles; Matthew Rubic; Christopher McKinnely; Alia Cibich; Mark R. Dowling; Stewart Hunt; Lynette C. Y. Chee; Ashleigh P. Scott; David S. Ritchie; Devendra Hiwase; Duncan Purtill; Abir Bhattacharya; Glen A. Kennedy; Ashish Bajel
errShare
errSave
Defining remission and relapse after allogeneic hematopoietic cell transplantation in myelodysplastic/myeloproliferative neoplasms and optimization of transplantation outcomes: Recommendations from the EBMT practice harmonisation and guidelines committee
errBone Marrow Transplantation
IF5.2
err2026-04-01
err0
PREAI
errChristopher Armstrong; Kavita Raj; Giorgia Battipaglia; Gonzalo Bentolila; Eolia Brissot; Yves Chalandon; Fernando Barroso Duarte; Joanna Drozd-Sokolowska; Vaneuza Funke; Nico Gagelmann; Thierry Guillaume; Carmelo Gurnari; Robert Hasserjian; Juan Carlos Hernández-Boluda; Devendra Hiwase; Andrés Jerez; Michael Loschi; Marin Medjugorac; Mufaddal T. Moonim; Francesco Onida; Nicola Polverelli; Micaela Quarchioni; Marie Robin; Christof Scheid; Katja Sockel; Daniel H. Wiseman; Annalisa Ruggeri; Isabel Sánchez-Ortega; Natalia Aranguiz Garcia; Mario Cazzola; Fabio Ciceri; Tomasz Czerw; Jaroslaw Maciejewski; Simona Pagliuca; Lisa Pleyer; Patryk Sobieralski; Jurjen Versluis; Maria Teresa Voso; Ibrahim Yakoub-Agha; Donal P. McLornan
errShare
errSave
Long-term survival gains after allogeneic hematopoietic stem cell transplant are driven by reductions in non-relapse mortality: A 35-Year Statewide Australian cohort study
errTransplantation and Cellular Therapy
IF4.4
err2026-01-20
err0
errOAAI
errAlia Cibich; Gauri Wechalekar; Naranie Shanmuganathan; Deepak Singhal; Ashanka Beligaswatte; Rebecca Wayte; Phil Selby; Susan Branford; David Yeung; Peter Bardy; Devendra Hiwase
errShare
errSave
Time to complete remission is an independent determinant of survival after intensive chemotherapy in AML
errBlood
IF23.1
err2025-07-31
err0
PREAI
errRithin Nedumannil; Michael Ashby; James Rowland; Jacques A. J. Malherbe; Jared Fairbank; Kelli Gray; Sun Loo; Matthew Wright; John Reynolds; Devendra Hiwase; Paula Marlton; Shaun Fleming; Ashish Bajel; Andrew H. Wei
errShare
errSave
RAS mutation identifies a poor prognostic molecular subtype of therapy-related myeloid neoplasm
errBlood Advances
IF7.1
err2025-05-26
err0
errOAAI
errChung Hoow Kok; Aref Al-Kali; Daniel Thomas; Rong He; Monika M. Kutyna; Hassan Alkhateeb; Kelly Lim; Antoine N. Saliba; Carla Toop; Aasiya Matin; Hamish Scott; Naseema Gangat; Anna Brown; Abhishek Mangaonkar; Christopher N. Hahn; Kebede Begna; Kevin Hung; Patricia Greipp; William J. Hogan; Mrinal Patnaik; Mithun Shah; Devendra K. Hiwase
errShare
errSave
RBC transfusion dependency refines the Molecular International Prognostic Scoring System for myelodysplastic syndrome
errBlood Advances
IF7.1
err2025-04-25
err0
errOAAI
errThomas Wiseman; Michaela Spooner; Shreyas Khanna; Kevin Hung; Carla R. Toop; Monika Kutyna; Joanne Yu; Anna Brown; Hamish Scott; Christopher Hahn; Chung Hoow Kok; Devendra Hiwase
errShare
errSave
Multihit TP53 Mutations in Myeloproliferative Neoplasms and Acute Myeloid Leukemia: Comparative Analysis of Survival and Risk Factors in 142 Informative Cases
errAMERICAN JOURNAL OF HEMATOLOGY
IF0
err2025-03-13
err1
PREAI
errFathima, S; Abdelmagid, M; Alsugair, A; Begna, KH; Al-Kali, A; Mangaonkar, AA; Pardanani, AD; Patnaik, MM; Mendoza, CJZ; He, R; Reichard, KK; Badar, T; Foran, JM; Palmer, J; Loscocco, GG; Guglielmelli, P; Vannucchi, AM; Orazi, A; Arber, DA; Hiwase, D; Shah, MV; Gangat, N; Tefferi, A
errShare
errSave
TP53-Mutated Myeloid Neoplasms: 2024 Update on Diagnosis, Risk-Stratification, and Management
errAMERICAN JOURNAL OF HEMATOLOGY
IF0
err2025-03-11
err1
errOAAI
errShah, MV; Arber, DA; Hiwase, DK
errShare
errSave
Haploinsufficiency of miR-143 and miR-145 reveal targetable dependencies in resistant del(5q) myelodysplastic neoplasm
errLEUKEMIA
IF13.4
err2025-02-25
err0
errOAAI
errGharaee, Nadia; Wegrzyn-Woltosz, Joanna; Jiang, Jihong; Akhade, Vijay Suresh; Bridgers, Joshua; Stubbins, Ryan J.; Hiwase, Devendra; Kutyna, Monika M.; Komrokji, Rami; Padron, Eric; Deng, Yu; Cole, Gary; Umlandt, Patricia; Fuller, Megan; Kim, Ada; Karsan, Aly
errShare
errSave
TP53 Mutations in Myeloproliferative Neoplasms: Context-Dependent Evaluation of Prognostic Relevance
errAMERICAN JOURNAL OF HEMATOLOGY
IF0
err2025-01-28
err4
errOAAI
errTefferi, A; Abdelmagid, M; Loscocco, GG; Fathima, S; Begna, KH; Al-Kali, A; Foran, J; Palmer, J; Badar, T; Patnaik, MM; Reichard, KK; He, R; Mendoza, CJZ; Shah, M; Orazi, A; Arber, DA; Pardanani, A; Vannucchi, AM; Hiwase, D; Gangat, N; Guglielmelli, P
errShare
errSave
What have we learned about TP53-mutated acute myeloid leukemia?
errBLOOD CANCER JOURNAL
IF11.6
err2024-11-19
err0
errOAAI
errShahzad, Moazzam; Amin, Muhammad Kashif; Daver, Naval G.; Shah, Mithun Vinod; Hiwase, Devendra; Arber, Daniel A.; Kharfan-Dabaja, Mohamed A.; Badar, Talha
errShare
errSave
Extended Rhesus and Kell Phenotype-Matched Red Blood Cell (RBC) Transfusions Reduce RBC Alloimmunization and RBC Transfusion Burden in Patients with Myeloid Neoplasm
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errSpooner, Michaela; Yu, Joanne; Wiseman, Thomas; Toop, Carla; Khanna, Shreyas; Kok, Chung How; Hiwase, Devendra
errShare
errSave
High Dose Ascorbate Reduces Interleukin-1 Beta Secretion in TET2 Mutant Monocytes and Demonstrates Excellent and in CMML Patients in Combination with Azacitidine
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errKamel, Maha M.; Robinson, Nirmal; Kutyna, Monika; Lim, Kelly; Thompson-Peach, Chloe; Lane, Steven W.; Yeung, David; Yong, Agnes S. M.; Ross, David M.; Hiwase, Devendra; Thomas, Daniel
errShare
errSave
CBL Variants in Chronic Myelomonocytic Leukemia Exhibit a Complex Sub-Clone Architecture with a High Frequency of RING Domain Mutations Sufficient to Induce GM-CSF Hypersensitivity
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errLim, Kelly; Kutyna, Monika; Kan, Winnie; Lopez, Angel F.; Brown, Anna; Yong, Agnes S. M.; Lane, Steven W.; Fong, Chun Yew; Hughes, Timothy P.; Yeung, David T.; Ross, David M.; Hiwase, Devendra; Thomas, Daniel
errShare
errSave
Improvements in Hematological Parameters and Quality of Life (QOL) with Elritercept (KER-050): Results from an Ongoing Phase 2 Trial in Participants with Lower-Risk (LR) Myelodysplastic Neoplasms (MDS)
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errGiagounidis, Aristoteles; Arnan, Monteserrat; Chee, Lynette C. Y.; Cluzeau, Thomas; Diez-Campelo, Maria; Hiwase, Devendra; Ross, David M.; Sekeres, Mikkael A.; Tan, Shuhying; Valcarcel, David; Buckstein, Rena; Patel-Shah, Bhavna; Yang, Ming; Jiang, Ying; Yin, Jiani; Bobba, Suresh; Hankin, Montagu; Materna, Chris; Graham, Christine; Thamake, Sanjay; Rovaldi, Christopher; Grayson, Dena; Salstrom, Jen L.
errShare
errSave
Clinical Response to Azacitidine in Myelodysplastic Neoplasms Is Associated with Distinct DNA Methylation Changes in Haematopoietic Stem and Progenitor Cells In Vivo
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errThoms, Julie A. I.; Yan, Feng; Hampton, Henry R.; Davidson, Sarah; Joshi, Swapna; Saw, Jesslyn; Sarowar, Chowdhury H.; Lim, Xin Ying; Nunez, Andrea C.; Kakadia, Purvi M.; Bhuyan, Golam Sarower; Zou, Xiaoheng; Nguyen, Mary; Ghodousi, Elaheh S.; Koch, Forrest C.; Vafaee, Fatemeh; Thompson, Richard; Karimi, Mohammad M.; Pickford, Russell; Raftery, Mark J.; Hough, Sally; Buckland, Griselda; Bailey, Michelle; Ghodke, Yuvaraj; Absar, Noorul; Vaughan, Lachlin; Pasalic, Leonardo; Fong, Chun Yew; Kenealy, Melita; Hiwase, Devendra; Stoddart, Rohanna; Mohammed, Soma; Lee, Linda; Passam, Freda H.; Larsen, Stephen Robert; Spring, Kevin J.; Skarratt, Kristen K.; Ling, Silvia; Stevenson, William S.; Presgrave, Peter; Rebeiro, Patricia; Tiley, Campbell; Fuller, Stephen; Roncolato, Fernando; Enjeti, K.; Hoenemann, Dirk; Lemech, Charlotte; Jolly, Christopher J.; Bohlander, Stefan K.; Curtis, David J.; Wong, Jason; Unnikrishnan, Ashwin; Enjeti, Anoop K.; Hertzberg, Mark S.; Olivier, Jake; Polizzotto, Mark N.; Pimanda, John E.
errShare
errSave
Impact of Chronic Inflammation and Cytotoxic Therapy on Bone Marrow Microenvironment of Patients with Autoimmune Rheumatic Diseases and Myeloid Neoplasms
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errKutyna, Monika; Thomas, Daniel; Hiwase, Devendra
errShare
errSave
A Phase II Randomized Trial Comparing Low-Dose Cytarabine and Venetoclax plus /- Midostaurin in Non-Adverse Cytogenetic Risk Acute Myeloid Leukemia: The ALLG AMLM25 Intervene Trial
errBLOOD
IF23.1
err2024-11-05
err0
PREAI
errChua, Chong Chyn; Hsu, Blake; Enjeti, Anoop K.; Bajel, Ashish; Marlton, Paula; Fleming, Shaun; Hiwase, Devendra; Ma, Chun Kei Kris; Browett, Peter J.; Perera, Travis; Grove, Carolyn S.; Tan, Shuhying; Othman, Jad; Cooney, Julian; Rose, Hannah; Morris, Edward S.; Koldej, Rachel; Ritchie, David S.; Mason, Kate; Anstee, Natasha S.; Reynolds, John; Wei, Andrew H.
errShare
errSave

Research Directions

No research directions
Co-authors
Cooperation Journals
J
Jörge E. Cortes
H-index: 179 · Papers: 3.6K
S
Steven M. Holland
H-index: 155 · Papers: 1.9K
A
Ayalew Tefferi
H-index: 152 · Papers: 2.1K
H
Hartmut Döhner
H-index: 146 · Papers: 1.4K
P
Pierre Fenaux
H-index: 130 · Papers: 1.8K
View more